On ECHEMI
Home > Drugs > Shandong Keyuan Pharmaceutical Co., Ltd.
Shandong Keyuan Pharmaceutical Co., Ltd.
  • Founded in:

    2004-12-27
  • Country:

    China China
  • Address:

    Keyuan Street, Shandong Shanghe Economic Development Zone, Jinan City, Shandong
  • Tax NO.:

    91370126771003840T
  • Registered Funds:

    108.29 million yuan
  • Website:

  • Email:

Related Drugs
Amlexanox
Name Description Content CAS NO. Registered Holders
Amlexanox

Extract from the above information

More

Extract from the above information

68302-57-8 4
Clarithromycin lactobionate
Name Description Content CAS NO. Registered Holders
CLARITHROMYCIN LACTOBIONATE

Unspecified

More

Unspecified

135326-55-5 2
Nisoldipine
Name Description Content CAS NO. Registered Holders
Nisoldipine

No specific pharmacological effects are clearly mentioned from the above information

More

No specific pharmacological effects are clearly mentioned from the above information

63675-72-9 12
Chlorzoxazone
Name Description Content CAS NO. Registered Holders
Chlorzoxazone

Extract from the above information

More

Extract from the above information

95-25-0 19
Isoflurane
Isoflurane.
Name Description Content CAS NO. Registered Holders
Isoflurane

Induction and recovery with isoflurane are very rapid. After inhalation of isoflurane, the pharyngeal and laryngeal reflexes weaken rapidly. The depth of isoflurane anesthesia changes rapidly, and the heart rhythm remains stable during the process. As the anesthesia deepens, spontaneous breathing will be suppressed. A drop in blood pressure may occur during isoflurane induction and return to normal with the start of surgical stimulation. During the maintenance of anesthesia, blood pressure tends to decrease with the depth of anesthesia, due to the expansion of peripheral blood vessels, and the heart rhythm remains stable at this time. Under mechanical ventilation and maintaining normal carbon dioxide partial pressure (PaCO2), cardiac output can be maintained even if the depth of anesthesia is increased, generally by compensating for it by increasing the heart rate. Cerebral blood flow remains unchanged under mild isoflurane anesthesia, but increases as the anesthesia deepens. Excessive cerebrospinal fluid pressure can be prevented or corrected by hyperventilating the patient before or during anesthesia. Isoflurane can cause increased sensitivity of the myocardium to adrenaline, but the degree is weaker than enflurane.

More

Induction and recovery with isoflurane are very rapid. After inhalation of isoflurane, the pharyngeal and laryngeal reflexes weaken rapidly. The depth of isoflurane anesthesia changes rapidly, and the heart rhythm remains stable during the process. As the anesthesia deepens, spontaneous breathing will be suppressed. A drop in blood pressure may occur during isoflurane induction and return to normal with the start of surgical stimulation. During the maintenance of anesthesia, blood pressure tends to decrease with the depth of anesthesia, due to the expansion of peripheral blood vessels, and the heart rhythm remains stable at this time. Under mechanical ventilation and maintaining normal carbon dioxide partial pressure (PaCO2), cardiac output can be maintained even if the depth of anesthesia is increased, generally by compensating for it by increasing the heart rate. Cerebral blood flow remains unchanged under mild isoflurane anesthesia, but increases as the anesthesia deepens. Excessive cerebrospinal fluid pressure can be prevented or corrected by hyperventilating the patient before or during anesthesia. Isoflurane can cause increased sensitivity of the myocardium to adrenaline, but the degree is weaker than enflurane.

26675-46-7 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.